서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 17 of 17

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2006-04	Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ERK1,2 and PI3K/Akt Kim, SH; Juhnn, YS; Kang, S; Park, SW; Sung, MW; Bang, YJ; Song, YS Cellular and Molecular Life Sciences, Vol.63 No.7-8, pp.930-938	DOI
2007-05	Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer Han, Sae-Won; Jeon, Yoon Kyung; Lee, Kyung-Hun; Keam, Bhumsuk; Hwang, Pil Gyu; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue; Kim, Tae-You Pharmacogenetics and Genomics, Vol.17 No.5, pp.313-319	DOI
2008-02	High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer Kim, D-W; Min, HS; Lee, K-H; Kim, YJ; Oh, D-Y; Jeon, YK; Lee, S-H; Im, S-A; Chung, DH; Kim, YT; Kim, T-Y; Bang, Y-J; Sung, SW; Kim, JH; Heo, DS Br J Cancer 98:1118-1124 (2008) 98, 1118–1124	link
2008-03	High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer Kim, D-W; Min, H. S.; Lee, K-H; Kim, Y. J.; Oh, D-Y; Jeon, Y. K.; Lee, S. -H.; Im, S. -A.; Chung, D. H.; Kim, Y. T.; Kim, T. -Y.; Bang, Y. -J.; Sung, S. W.; Kim, J. H.; Heo, D. S. British Journal of Cancer, Vol.98 No.6, pp.1118-1124	DOI
2008-04	EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number Kim, M A; Lee, H S; Lee, H E; Jeon, Y K; Yang, H K; Kim, W H Histopathology 2008; 52; 738-746	DOI
2009	Pathologic and molecular characteristics with prognostic implication of mucinous gastric carcinomas 최종순	link
2009-01	Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer Han, S-W; Oh, D-Y; Im, S-A; Park, S. R.; Lee, K-W; Song, H. S.; Lee, N-S; Lee, K. H.; Choi, I. S.; Lee, M. H.; Kim, M. A.; Kim, W. H.; Bang, Y-J; Kim, T-Y British Journal of Cancer, Vol.100 No.2, pp.298-304	DOI
2009-03	Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival Kim, J. -S.; Kim, M. -A.; Kim, T. M.; Lee, S. -H.; Kim, D. -W.; Im, S. -A.; Kim, T. -Y.; Kim, W. H.; Yang, H. -K.; Heo, D. S.; Bang, Y. -J.; Lee, K. -U.; Choe, K. -J.; Kim, N. K. British Journal of Cancer, Vol.100 No.5, pp.732-738	DOI
2009-08	Mucinous Gastric Carcinomas Clinicopathologic and Molecular Analyses Choi, Jong Sun; Kim, Min A.; Lee, Hee Eun; Lee, Hye Seung; Kim, Woo Ho CANCER; Vol.115 15; 3581-90	DOI
2012-07	Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer Lee, June Koo; Park, Heae Surng; Kim, Dong-Wan; Kulig, Kimary; Kim, Tae Min; Lee, Se-Hoon; Jeon, Yoon-Kyung; Chung, Doo Hyun; Heo, Dae Seog; Kim, Woo-Ho; Bang, Yung-Jue Cancer, Vol.118 No.14, pp.3579-3586	DOI
2013-02	Comparative analysis of overall survival of patient with non-small cell lung cancer harboring anaplastic lymphoma kinase fusion 이준구	view file
2014-06	Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer Lee, Yun-Gyoo; Kim, Inho; Lee, Eunyoung; Bang, Soo-Mee; Kang, Chang Hyun; Kim, Young Tae; Kim, Hak Jae; Wu, Hong-Gyun; Kim, Young Whan; Kim, Tae Min; Lee, Keun-Wook; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Thrombosis and Haemostasis, Vol.111 No.6, pp.1112-1120	view file DOI
2016-03	Pretreatment albumin-to-globulin ratio as a predictive marker for tyrosine kinase inhibitor in non-small cell lung cancer Park, Sehhoon; Park, Seongyeol; Lee, Se-Hoon; Suh, Beomseok; Ock, Chan-Young; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Kim, Young Whan; Heo, Dae Seog Cancer Biomarkers, Vol.16 No.3, pp.425-433	DOI
2017-02	A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) Kim, Hye Ryun; Jang, Joung Soon; Sun, Jong-Mu; Ahn, Myung-Ju; Kim, Dong-Wan; Jung, Inkyung; Lee, Ki Hyeong; Kim, Joo-Hang; Lee, Dae Ho; Kim, Sang-We; Cho, Byoung Chul Oncotarget, Vol.8 No.9, pp.15943-15951	view file DOI
2018-02	Droplet digital PCR-based EGFR mutation detection with an internal quality control index to determine the quality of DNA 김성수	view file
2021-05	Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study Park, Keunchil; Janne, Pasi A.; Kim, Dong-Wan; Han, Ji-Youn; Wu, Ming-Fang; Lee, Jong-Seok; Kang, Jin-Hyoung; Lee, Dae Ho; Cho, Byoung Chul; Yu, Chong-Jen; Pang, Yong Kek; Felip, Enriqueta; Kim, Hyunjin; Baek, Eunhye; Noh, Young Su Cancer, Vol.127 No.9, pp.1407-1416	DOI
2022-07	A phase 1b/2 study of PF-06747775 as monotherapy or in combination with Palbociclib in patients with epidermal growth factor receptor mutant advanced non-small cell lung cancer Cho, Byoung Chul; Goldberg, Sarah B.; Kim, Dong-Wan; Socinski, Mark A.; Burns, Timothy F.; Lwin, Zarnie; Pathan, Nuzhat; Ma, Wei Dong; Masters, Joanna C.; Cossons, Nandini; Wilner, Keith; Nishio, Makoto; Husain, Hatim Expert Opinion on Investigational Drugs, Vol.31 No.7, pp.747-757

1